Next-Generation Ocular Delivery Systems

Envisioning a paradigm shift in ocular delivery systems, this concept combines cutting-edge technologies such as nanofluidics, artificial intelligence, bioresorbable materials, and machine learning to revolutionize the treatment of glaucoma and other eye disorders.

The original patent disclosed systems and methods for accessing Schlemm's canal, delivering a fluid composition, and performing a trabeculotomy. However, these systems have limitations in terms of precision, efficacy, and personalized treatment. The new inventive concept addresses these limitations by introducing advanced technologies that enable targeted, real-time, and adaptive ocular delivery.

The next-generation ocular delivery systems comprise a nanofluidic device integrated with an AI-powered navigation system to optimize fluid flow and pressure within Schlemm's canal. The system can be combined with bioresorbable micro-devices that release controlled amounts of therapeutic agents over predetermined periods. Additionally, wearable sensor arrays and machine learning-based analytics platforms can provide real-time monitoring of ocular pressure and fluid flow, enabling predictive and preventive glaucoma treatment. The systems can also be personalized through genetic profiling and 3D-printed customized implants.

The new claims introduce a fundamental shift in ocular delivery systems by incorporating AI, nanofluidics, bioresorbable materials, and machine learning. These advancements enable unprecedented precision, adaptability, and personalized treatment, making the original patent's concepts obsolete.

Alternative embodiments may include using different types of AI algorithms, integrating the systems with other medical devices, or developing implantable sensors for continuous monitoring. Variations may include using different materials, shapes, or sizes for the nanofluidic devices or bioresorbable micro-devices.

The next-generation ocular delivery systems have vast commercial potential in the ophthalmology and pharmaceutical industries, with potential applications in treating glaucoma, cataracts, and other eye disorders. The market for these systems is expected to grow significantly as the technology advances and becomes more widely adopted.